Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Z Siddiqui, AN Srivastava, SN Sankhwar, D Dalela, V Singh, N Zaidi, N Fatima, I Bano & S Anjum. (2020) Synergic effects of cancer stem cells markers, CD44 and embryonic stem cell transcription factor Nanog, on bladder cancer prognosis. British Journal of Biomedical Science 77:2, pages 69-75.
Read now
Read now
Guichuan Huang, Jing Zhang, Xin Wang, Yi Chen, Daishun Liu & Shuliang Guo. (2019) Clinicopathological and prognostic significance of Nanog expression in non-small cell lung cancer: a meta-analysis. OncoTargets and Therapy 12, pages 3609-3617.
Read now
Read now
Articles from other publishers (15)
Letícia Antunes Muniz Ferreira, Maria Antonia dos Santos Bezerra, Rosa Sayoko Kawasaki-Oyama, Glaucia Maria de Mendonça Fernandes, Márcia Maria Urbanin Castanhole-Nunes, Vilson Serafim Junior, Rogério Moraes Castilho, Érika Cristina Pavarino, José Victor Maniglia & Eny Maria Goloni-Bertollo. (2023) Effect of ZEB1 Associated with microRNAs on Tumor Stem Cells in Head and Neck Cancer. International Journal of Molecular Sciences 24:6, pages 5916.
Crossref
Crossref
Yiwei Li, Asfar S. Azmi & Ramzi M. Mohammad. (2022) Deregulated transcription factors and poor clinical outcomes in cancer patients. Seminars in Cancer Biology 86, pages 122-134.
Crossref
Crossref
Methaq Al-Kaabi, Khalida Noel & Abdal-jabbar Al-Rubai. (2022) Evaluation of immunohistochemical expression of stem cell markers (NANOG and CD133) in normal, hyperplastic, and malignant endometrium. Journal of Medicine and Life 15:1, pages 117-123.
Crossref
Crossref
Yakelin Díaz-Tejeda, Miriam C. Guido-Jiménez, Helga López-Carbajal, Alfredo Amador-Molina, Rocío Méndez-Martínez, Patricio Gariglio-Vidal, Marcela Lizano & Alejandro García-Carrancá. (2021) Nanog, in Cooperation with AP1, Increases the Expression of E6/E7 Oncogenes from HPV Types 16/18. Viruses 13:8, pages 1482.
Crossref
Crossref
Toru Narusaka, Toshiaki Ohara, Kazuhiro Noma, Noriyuki Nishiwaki, Yuki Katsura, Takuya Kato, Hiroaki Sato, Yasuko Tomono, Satoru Kikuchi, Hiroshi Tazawa, Yasuhiro Shirakawa, Akihiro Matsukawa & Toshiyoshi Fujiwara. (2021) Nanog is a promising chemoresistant stemness marker and therapeutic target by iron chelators for esophageal cancer. International Journal of Cancer 149:2, pages 347-357.
Crossref
Crossref
Xinyuan Tong, Yueqing Chen, Xinsheng Zhu, Yi Ye, Yun Xue, Rui Wang, Yijun Gao, Wenjing Zhang, Weiqiang Gao, Lei Xiao, Haiquan Chen, Peng Zhang & Hongbin Ji. (2021)
Nanog
maintains stemness of
Lkb1
‐deficient lung adenocarcinoma and prevents gastric differentiation
. EMBO Molecular Medicine 13:3.
Crossref
Crossref
Neda Khosravi, Vahid Khaze Shahgoli, Mohammad Amini, Sahar Safaei, Ahad Mokhtarzadeh, Behzad Mansoori, Afshin Derakhshani, Amir Baghbanzadeh & Behzad Baradaran. (2021) Suppression of Nanog inhibited cell migration and increased the sensitivity of colorectal cancer cells to 5-fluorouracil. European Journal of Pharmacology 894, pages 173871.
Crossref
Crossref
Gašper Grubelnik, Emanuela Boštjančič, Aleksandar Aničin, Tadej Dovšak & Nina Zidar. (2021) MicroRNAs and Long Non-Coding RNAs as Regulators of NANOG Expression in the Development of Oral Squamous Cell Carcinoma. Frontiers in Oncology 10.
Crossref
Crossref
Gašper Grubelnik, Emanuela Boštjančič, Aleš Grošelj & Nina Zidar. (2020) Expression of NANOG and Its Regulation in Oral Squamous Cell Carcinoma. BioMed Research International 2020, pages 1-12.
Crossref
Crossref
Filip Sedlic, Fran Seiwerth, Ana Sepac, Suncana Sikiric, Marina Cindric, Marija Milavic, Lovorka Batelja Vuletic, Marko Jakopovic & Sven Seiwerth. (2020) Mitochondrial ROS Induce Partial Dedifferentiation of Human Mesothelioma via Upregulation of NANOG. Antioxidants 9:7, pages 606.
Crossref
Crossref
Daniel Pedregal-Mallo, Francisco Hermida-Prado, Rocío Granda-Díaz, Irene Montoro-Jiménez, Eva Allonca, Esperanza Pozo-Agundo, Mónica Álvarez-Fernández, César Álvarez-Marcos, Juana M. García-Pedrero & Juan Pablo Rodrigo. (2020) Prognostic Significance of the Pluripotency Factors NANOG, SOX2, and OCT4 in Head and Neck Squamous Cell Carcinomas. Cancers 12:7, pages 1794.
Crossref
Crossref
Monica Mossenta, Davide Busato, Michele Dal Bo & Giuseppe Toffoli. (2020) Glucose Metabolism and Oxidative Stress in Hepatocellular Carcinoma: Role and Possible Implications in Novel Therapeutic Strategies. Cancers 12:6, pages 1668.
Crossref
Crossref
Claudia Ramírez-Rentería, Ana Laura Espinosa-De-Los-Monteros, Espinosa-Cardenas Etual, Daniel Marrero-Rodríguez, Guillermo Castellanos, Rocio Arreola-Rosales, Guillermo Montoya-Martinez, Keiko Taniguchi-Ponciano, Paola Briseño-Díaz, Mayte Lizeth Padilla-Cristerna, María del Pilar Figueroa-Corona & Mercado Moises. (2020) From ACTH-Dependent to ACTH-Independent Cushing’s Syndrome from a Malignant Mixed Corticomedullary Adrenal Tumor: Potential Role of Embryonic Stem Cells. Case Reports in Endocrinology 2020, pages 1-9.
Crossref
Crossref
Gašper Grubelnik, Emanuela Boštjančič, Ana Pavlič, Marina Kos & Nina Zidar. (2020) NANOG expression in human development and cancerogenesis. Experimental Biology and Medicine 245:5, pages 456-464.
Crossref
Crossref
Peng Tan, Yunke Xu, Yichao Du, Lile Wu, Bing Guo, Shiyao Huang, Jinhui Zhu, Bo Li, Fujun Lin & Lei Yao. (2019) SPOP suppresses pancreatic cancer progression by promoting the degradation of NANOG. Cell Death & Disease 10:11.
Crossref
Crossref